Higher CD47 mRNA transcripts have been seen in primary DLBCL samples from patients refractory to chemoimmunotherapy, and blockade of the CD47-SIRPα interaction enhances the phagocytosis of various NHL cell lines in vitro [136]. The gene discussed is CD47; the disease is non-Hodgkin lymphoma.